|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cambier S, Sylvester RJ, Collette L,
Gontero P, Brausi MA, van Andel G, Kirkels WJ, Silva FC,
Oosterlinck W, Prescott S, et al: EORTC nomograms and risk groups
for predicting recurrence, progression, and disease-specific and
overall survival in non-muscle-invasive stage Ta-T1 urothelial
bladder cancer patients treated with 1–3 years of maintenance
Bacillus Calmette-Guérin. Eur Urol. 69:60–69. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gakis G, Efstathiou J, Lerner SP, Cookson
MS, Keegan KA, Guru KA, Shipley WU, Heidenreich A, Schoenberg MP,
Sagaloswky AI, et al International Consultation on Urologic
Disease-European Association of Urology Consultation on Bladder
Cancer 2012, : ICUD-EAU International Consultation on Bladder
Cancer 2012: Radical cystectomy and bladder preservation for
muscle-invasive urothelial carcinoma of the bladder. Eur Urol.
63:45–57. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gakis G, Black PC, Bochner BH, Boorjian
SA, Stenzl A, Thalmann GN and Kassouf W: Systematic Review on the
Fate of the Remnant Urothelium after Radical Cystectomy. Eur Urol.
71:545–557. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Choi S, Shin JH, Lee YR, Joo HK, Song KH,
Na YG, Chang SJ, Lim JS and Jeon BH: Urinary APE1/Ref-1: A
potential bladder cancer biomarker. Dis Markers. 2016:72765022016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li Q, Wei X, Zhou ZW, Wang SN, Jin H, Chen
KJ, Luo J, Westover KD, Wang JM, Wang D, et al: GADD45α sensitizes
cervical cancer cells to radiotherapy via increasing cytoplasmic
APE1 level. Cell Death Dis. 9:5242018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lu GS, Li M, Xu CX and Wang D: APE1
stimulates EGFR-TKI resistance by activating Akt signaling through
a redox-dependent mechanism in lung adenocarcinoma. Cell Death Dis.
9:11112018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang S, He L, Dai N, Guan W, Shan J, Yang
X, Zhong Z, Qing Y, Jin F, Chen C, et al: Serum APE1 as a
predictive marker for platinum-based chemotherapy of non-small cell
lung cancer patients. Oncotarget. 7:77482–77494. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shin JH, Choi S, Lee YR, Park MS, Na YG,
Irani K, Lee SD, Park JB, Kim JM, Lim JS, et al: APE1/Ref-1 as a
serological biomarker for the detection of bladder cancer. Cancer
Res Treat. 47:823–833. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sun Y and Nelson PS: Molecular pathways:
Involving microenvironment damage responses in cancer therapy
resistance. Clin Cancer Res. 18:4019–4025. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Olsson AK, Dimberg A, Kreuger J and
Claesson-Welsh L: VEGF receptor signalling - in control of vascular
function. Nat Rev Mol Cell Biol. 7:359–371. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Georganaki M, van Hooren L and Dimberg A:
Vascular targeting to increase the efficiency of immune checkpoint
blockade in cancer. Front Immunol. 9:30812018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wheeler KC, Jena MK, Pradhan BS, Nayak N,
Das S, Hsu CD, Wheeler DS, Chen K and Nayak NR: VEGF may contribute
to macrophage recruitment and M2 polarization in the decidua. PLoS
One. 13:e01910402018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sica A, Allavena P and Mantovani A: Cancer
related inflammation: The macrophage connection. Cancer Lett.
267:204–215. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Takayama H, Nishimura K, Tsujimura A,
Nakai Y, Nakayama M, Aozasa K, Okuyama A and Nonomura N: Increased
infiltration of tumor associated macrophages is associated with
poor prognosis of bladder carcinoma in situ after intravesical
bacillus Calmette-Guerin instillation. J Urol. 181:1894–1900. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sjödahl G, Lövgren K, Lauss M, Chebil G,
Patschan O, Gudjonsson S, Månsson W, Fernö M, Leandersson K,
Lindgren D, et al: Infiltration of CD3+ and
CD68+ cells in bladder cancer is subtype specific and
affects the outcome of patients with muscle-invasive tumors. Urol
Oncol. 32:791–797. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Q, Zhang T, Wu J, Wen J, Tao D, Wan T
and Zhu W: Prognosis and risk factors of patients with upper
urinary tract urothelial carcinoma and postoperative recurrence of
bladder cancer in central China. BMC Urol. 19:242019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Epstein JI, Amin MB, Reuter VR and Mostofi
FK; Bladder Consensus Conference Committee, : The World Health
Organization/International Society of Urological Pathology
consensus classification of urothelial (transitional cell)
neoplasms of the urinary bladder. Am J Surg Pathol. 22:1435–1448.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Amin MB, Edge SB, Greene FL, Schilsky RL,
Gaspar LE and Washington M: AJCC Cancer Staging Manual. Springer.
(New York, NY). 2017. View Article : Google Scholar
|
|
20
|
Gorris MA, Halilovic A, Rabold K, van
Duffelen A, Wickramasinghe IN, Verweij D, Wortel IM, Textor JC, de
Vries IJ and Figdor CG: Eight-color multiplex immunohistochemistry
for simultaneous detection of multiple immune checkpoint molecules
within the tumor microenvironment. J Immunol. 200:347–354. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang Y, Hong YK, Zhuang DW, He XJ and Lin
ME: Bladder cancer survival nomogram: Development and validation of
a prediction tool, using SEER and TCGA databases. Medicine
(Baltimore). 98:e177252019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim H, Kim M, Kwak C, Kim HH and Ku JH:
Prognostic significance of lymphovascular invasion in radical
cystectomy on patients with bladder cancer: A systematic review and
meta-analysis. PLoS One. 9:e892592014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Burger M, Catto JW, Dalbagni G, Grossman
HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, La Vecchia C,
Shariat S, et al: Epidemiology and risk factors of urothelial
bladder cancer. Eur Urol. 63:234–241. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zharkov DO: Base excision DNA repair. Cell
Mol Life Sci. 65:1544–1565. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Evans AR, Limp-Foster M and Kelley MR:
Going APE over ref-1. Mutat Res. 461:83–108. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fishel ML, Xia H, McGeown J, McIlwain DW,
Elbanna M, Craft AA, Kaimakliotis HZ, Sandusky GE, Zhang C, Pili R,
et al: Anti-tumor activity and mechanistic characterization of
APE1/Ref-1 inhibitors in bladder cancer. Mol Cancer Ther.
18:1947–1960. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang D, Zhong ZY, Li MX, Xiang DB and Li
ZP: Vector-based Ape1 small interfering RNA enhances the
sensitivity of human osteosarcoma cells to endostatin in vivo.
Cancer Sci. 98:1993–2001. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pignot G, Bieche I, Vacher S, Güet C,
Vieillefond A, Debré B, Lidereau R and Amsellem-Ouazana D:
Large-scale real-time reverse transcription-PCR approach of
angiogenic pathways in human transitional cell carcinoma of the
bladder: Identification of VEGFA as a major independent prognostic
marker. Eur Urol. 56:678–688. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kloepper J, Riedemann L, Amoozgar Z, Seano
G, Susek K, Yu V, Dalvie N, Amelung RL, Datta M, Song JW, et al:
Ang-2/VEGF bispecific antibody reprograms macrophages and resident
microglia to anti-tumor phenotype and prolongs glioblastoma
survival. Proc Natl Acad Sci USA. 113:4476–4481. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Thorsson V, Gibbs DL, Brown SD, Wolf D,
Bortone DS, Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA,
et al: The Immune Landscape of Cancer. Immunity. 48:812–830.e814.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hudson AL, Parker NR, Khong P, Parkinson
JF, Dwight T, Ikin RJ, Zhu Y, Chen J, Wheeler HR and Howell VM:
Glioblastoma Recurrence Correlates With Increased APE1 and
Polarization Toward an Immuno-Suppressive Microenvironment. Front
Oncol. 8:3142018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yan T, Venkat P, Chopp M, Zacharek A, Yu
P, Ning R, Qiao X, Kelley MR and Chen J: APX3330 promotes
neurorestorative effects after stroke in type one diabetic rats.
Aging Dis. 9:453–466. 2018. View Article : Google Scholar : PubMed/NCBI
|
